| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Sales of products and services | 0 | 0 | - | - |
| Cost of goods and services sold | 0 | 0 | - | - |
| Gross profit | 0 | 0 | - | - |
| Other operating expenses | - | - | 42,252 | 87,415 |
| Employee compensation | 192,869 | 183,864 | 205,800 | 220,118 |
| Occupancy | 46,920 | 49,723 | 174,624 | 175,646 |
| Depreciation and amortization of property and equipment | 41,893 | 41,744 | 41,263 | 45,995 |
| Amortization of intangible assets | 1,694 | 3,400 | 3,360 | 3,590 |
| Other operating expenses | 26,758 | -29,032 | - | - |
| Total operating expenses | 310,134 | 249,699 | 467,299 | 532,764 |
| Income (loss) from operations | -310,134 | -249,699 | -467,299 | -532,764 |
| Loss on obsolete inventory | 0 | 0 | - | -88,338 |
| Interest income (expense) | - | - | -19 | - |
| Interest expense | 18 | 23 | - | 49 |
| Total other income (expenses) | -18 | -23 | -19 | -88,289 |
| Loss before provision for income tax | -310,152 | -249,722 | -467,318 | -621,053 |
| Provision for income tax | 0 | 0 | - | - |
| Net loss | - | -249,722 | -467,318 | - |
| Net loss | -310,152 | -230,333 | -435,630 | -621,053 |
| Net loss attributable to non-controlling interest | -33,381 | -19,389 | -31,688 | -40,210 |
| Net loss attributable to common stockholders | -276,771 | - | - | -580,843 |
| Net loss per share basic and diluted | 0 | 0 | 0 | -0.01 |
| Weighted average common shares outstanding basic and diluted | 147,870,790 | 119,820,790 | 119,820,790 | 119,820,790 |
Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd (YBGJ)